Health Care Startup Cencora Appoints Robert Sanchez to Its Board of Directors

Sanchez is currently Executive Chair of Ryder System. He previously served as Chair and CEO of Ryder until retiring as CEO in March 2026.

Before becoming CEO in 2013, Sanchez spent 20 years at Ryder in several senior roles, including President and COO, President of Global Fleet Management Solutions, and Executive Vice President and CFO.

Read More:Electronics Manufacturer Rexel Acquires Illinois-Based GCG

Sanchez currently serves on the Board of Directors of Texas Instruments and is a Trustee of the University of Miami. He holds an MBA from the Wharton School at the University of Pennsylvania and a Bachelor of Science degree from the University of Miami.

“Robert’s experience as a public-company CEO, including his deep understanding of logistics and supply chains, will complement the Board’s skill set as we support Cencora’s pharmaceutical-centric strategy. His appointment reflects the Board’s ongoing commitment to leaders whose perspectives will further the company’s growth ambitions,” said Mark Durcan, Chair of Cencora’s Board of Directors.

“Throughout his career at Ryder, Mr. Sanchez has shaped a thoughtful approach to strategy, execution and long-term value creation. His breadth of experience across operations, finance and technology will add valuable insight as we advance Cencora’s priorities and drive sustained growth,” said Robert P. Mauch, President and Chief Executive Officer of Cencora.

About Cencora

Cencora is a global pharmaceutical solutions company focused on improving healthcare for people and animals. The company works with pharmaceutical companies to help bring medicines to patients and provides healthcare providers with reliable delivery of medicines, healthcare products and related solutions.

Read More:Colorado-Based Mesa Quantum Raises $11.8M in Funding